NEW YORK (GenomeWeb News) – Olink Bioscience said today that it has signed up Genetix Biotech Asia to distribute its proximity ligation assay product line in India and Southeast Asia.

Uppsala, Sweden-based Olink said that the South Asian region represents a new market for its Duolink reagents, because it has “an increasing number of academic and industrial partners.”

The firm said that its Duolink products extend the capabilities of immunoflourescence and immunohistochemistry to include direct detection of proteins, protein interactions, and modifications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.